Global GMP-Grade Process Enzymes for mRNA Manufacturing Supply, Demand and Key Producers, 2026-2032
The global GMP-Grade Process Enzymes for mRNA Manufacturing market size is expected to reach $ 358 million by 2032, rising at a market growth of 13.5% CAGR during the forecast period (2026-2032).
GMP-Grade Process Enzymes for mRNA Manufacturing are high-purity recombinant enzymes and process-support proteins manufactured under controlled quality systems for the production of clinical and commercial mRNA drug substances and vaccines. These products are generally supplied as concentrated liquid formulations and are measured by the physical weight of the finished enzyme solution, which contains the active protein, buffer components, salts, stabilizers and other formulation materials. The research scope covers enzymes used in DNA template preparation and linearization, in vitro transcription, RNA protection, 5? capping, cap methylation, polyadenylation and residual DNA removal. Core products include T7 RNA polymerase, restriction enzymes, inorganic pyrophosphatase, RNase inhibitor, RNA capping enzymes, methyltransferases, poly(A) polymerase and RNase-free DNase I. Key specifications include enzyme activity concentration, RNA yield and integrity, double-stranded RNA formation, impurity levels, endotoxin, bioburden, formulation stability, batch consistency and compatibility with scaled mRNA manufacturing. The principal applications include prophylactic infectious disease vaccines, individualized cancer immunotherapies, protein replacement therapies, in vivo gene-editing therapies and other therapeutic mRNA programs.
Downstream customers include mRNA vaccine manufacturers, therapeutic mRNA developers, pharmaceutical companies and mRNA-focused CDMOs. Process enzymes account for a limited proportion of total drug-manufacturing costs, but their performance directly affects RNA yield, integrity, impurity burden and batch-release outcomes. Products that reduce batch failure or simplify downstream purification can maintain premium pricing. However, higher activity concentrations and larger package sizes can lower the physical formulation weight required for a given production output, meaning volume growth in kilograms may be slower than growth in the number of clinical and commercial manufacturing programs.
The market is also differentiated by regulatory support and formulation concentration. Drug-master-file-supported GMP products generally occupy the highest-value tier, followed by standardized catalog GMP products and customized GMP products developed for specific customer programs. High-concentration formulations reduce transportation, storage and handling requirements and may lower the number of kilograms needed per production batch. As a result, segment performance should be evaluated through a combination of sales value, formulation weight and enzyme activity rather than physical volume alone.
China is the most active market for supplier localization. Domestic manufacturers have expanded from research reagents into GMP-grade T7 RNA polymerase, DNase I, capping enzymes, methyltransferases and other in vitro transcription materials. This development is shortening delivery cycles, increasing price competition and reducing dependence on imported products. Japan remains focused on specialist high-quality supply, while China Taiwan has developed a smaller base of commercial GMP RNA-production enzyme manufacturers. Other Asian markets currently have greater significance as downstream development and manufacturing locations than as independent suppliers of broad GMP enzyme portfolios.
This report is a detailed and comprehensive analysis of the world market for GMP-Grade Process Enzymes for mRNA Manufacturing and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GMP-Grade Process Enzymes for mRNA Manufacturing that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GMP-Grade Process Enzymes for mRNA Manufacturing market
2. What is the demand of the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
3. What is the year over year growth of the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
4. What is the production and production value of the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
5. Who are the key producers in the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
6. What are the growth factors driving the market demand?
GMP-Grade Process Enzymes for mRNA Manufacturing are high-purity recombinant enzymes and process-support proteins manufactured under controlled quality systems for the production of clinical and commercial mRNA drug substances and vaccines. These products are generally supplied as concentrated liquid formulations and are measured by the physical weight of the finished enzyme solution, which contains the active protein, buffer components, salts, stabilizers and other formulation materials. The research scope covers enzymes used in DNA template preparation and linearization, in vitro transcription, RNA protection, 5? capping, cap methylation, polyadenylation and residual DNA removal. Core products include T7 RNA polymerase, restriction enzymes, inorganic pyrophosphatase, RNase inhibitor, RNA capping enzymes, methyltransferases, poly(A) polymerase and RNase-free DNase I. Key specifications include enzyme activity concentration, RNA yield and integrity, double-stranded RNA formation, impurity levels, endotoxin, bioburden, formulation stability, batch consistency and compatibility with scaled mRNA manufacturing. The principal applications include prophylactic infectious disease vaccines, individualized cancer immunotherapies, protein replacement therapies, in vivo gene-editing therapies and other therapeutic mRNA programs.
Key Findings
- 2025 global GMP-Grade Process Enzymes for mRNA Manufacturing was approximately 520 Kg
- 2026 global GMP-Grade Process Enzymes for mRNA Manufacturing is estimated at approximately 600 Kg
- Weighted average prices were approximately US$279 per Kg
- T7 RNA polymerase represented approximately 48% of total market value
- North America remained the largest downstream demand region
Market Trends
The GMP-Grade Process Enzymes for mRNA Manufacturing market is moving from conventional recombinant products toward engineered enzymes with higher transcription efficiency, improved full-length RNA yield and lower double-stranded RNA formation. Low-dsRNA T7 RNA polymerases, high-activity concentrated formulations and products optimized for long or structurally complex RNA templates are receiving greater attention in clinical and commercial process development. Customer requirements are also shifting from individual reagent procurement toward qualified enzyme portfolios supported by batch-release documentation, change-control procedures, audit access, drug master files and long-term supply arrangements. As commercial production scales increase, customers place greater emphasis on reducing formulation volume, simplifying material handling and maintaining lot-to-lot consistency. Process-route changes are simultaneously reshaping demand: co-transcriptional capping can reduce post-transcriptional capping enzyme consumption, while template-encoded poly(A) sequences can limit the use of poly(A) polymerase.Market Dynamics
Drivers
Growth is primarily driven by the expansion of mRNA technology from COVID-19 vaccines into individualized cancer immunotherapies, next-generation infectious disease vaccines, protein replacement therapies and in vivo gene-editing programs. These applications require repeated GMP production campaigns, process validation batches and qualified raw-material supply. Personalized therapies generally use smaller but more frequent batches, increasing enzyme consumption related to process changeover, release testing, validation losses and safety-stock requirements. Demand is further supported by pharmaceutical companies and CDMOs qualifying second suppliers, regionalizing critical raw materials and requiring animal-origin-free manufacturing and stronger regulatory documentation. Engineered enzymes that increase RNA yield or reduce downstream purification burdens also support value growth despite gradual price pressure.Restraints
Market expansion is limited by declining unit prices, increased purchasing power among large pharmaceutical customers and growing competition from regional suppliers. The weighted average price per kilogram varies significantly according to enzyme type, activity concentration, formulation composition, package size and regulatory support. Large commercial customers generally obtain substantially lower prices than catalog users through industrial packaging and long-term contracts. Some mRNA developers also maintain internal enzyme-production capabilities or use dedicated supply arrangements outside the merchant market. In addition, alternative process routes can reduce demand for selected products, particularly enzymatic capping and polyadenylation enzymes.Opportunities
The strongest opportunities are concentrated in engineered T7 RNA polymerases with low dsRNA formation, high activity concentration and improved performance on difficult templates. Suppliers that can provide a continuous pathway from development-grade materials to clinical and commercial GMP products are well positioned to enter customer processes before final qualification. Additional opportunities exist in drug-master-file-supported enzymes, customized formulations, industrial package sizes, regional manufacturing and integrated portfolios covering template preparation, transcription and post-transcriptional processing. China and other Asian markets offer further potential as local mRNA developers seek shorter lead times, domestic sourcing and reduced dependence on imported enzymes.Challenges
The industry continues to face challenges related to standardization, regulatory interpretation and demand forecasting. The finished formulation weight does not directly represent active protein content because each product contains different concentrations of enzymes, buffers and stabilizers. Weighted average prices per kilogram therefore vary substantially across product mixes and cannot be directly compared without considering activity levels and enzyme type. Activity-unit definitions also differ among enzymes and suppliers, complicating technical benchmarking and supplier switching. Qualification may require comparability studies, analytical bridging and regulatory updates, while demand remains sensitive to clinical trial outcomes, vaccination cycles and changes in therapeutic development pipelines.Industry Chain Analysis
The upstream segment includes expression strains, plasmid constructs, fermentation media, process chemicals, chromatography resins, filtration membranes, single-use components, analytical reagents and GMP manufacturing infrastructure. Midstream enzyme manufacturers conduct sequence engineering, strain development, fermentation, purification, formulation, sterile filling, quality control and regulatory-documentation preparation. Physical sales volume is measured by the weight of the finished enzyme formulation rather than pure enzyme protein, as commercial products contain active proteins together with buffers, salts, glycerol and stabilizers. Value creation is therefore determined not only by formulation weight but also by enzyme activity, impurity control, stability, process reproducibility and regulatory support.Downstream customers include mRNA vaccine manufacturers, therapeutic mRNA developers, pharmaceutical companies and mRNA-focused CDMOs. Process enzymes account for a limited proportion of total drug-manufacturing costs, but their performance directly affects RNA yield, integrity, impurity burden and batch-release outcomes. Products that reduce batch failure or simplify downstream purification can maintain premium pricing. However, higher activity concentrations and larger package sizes can lower the physical formulation weight required for a given production output, meaning volume growth in kilograms may be slower than growth in the number of clinical and commercial manufacturing programs.
Segment Insights
RNA transcription polymerases represent the largest product segment, with T7 RNA polymerase accounting for approximately 45% to 52% of total market value. This position reflects its use across mainstream in vitro transcription platforms, relatively high consumption and the increasing adoption of engineered low-dsRNA products. DNA template removal enzymes, template linearization enzymes and inorganic pyrophosphatase provide stable process-wide demand because they support standard template preparation, transcription and post-transcriptional cleanup. RNA capping enzymes, cap methyltransferases and poly(A) polymerase occupy smaller but higher-value niches, with demand closely linked to the selected manufacturing route.The market is also differentiated by regulatory support and formulation concentration. Drug-master-file-supported GMP products generally occupy the highest-value tier, followed by standardized catalog GMP products and customized GMP products developed for specific customer programs. High-concentration formulations reduce transportation, storage and handling requirements and may lower the number of kilograms needed per production batch. As a result, segment performance should be evaluated through a combination of sales value, formulation weight and enzyme activity rather than physical volume alone.
Downstream Market Opportunities
Prophylactic infectious disease vaccines remain the largest established downstream application because they generate the highest commercial mRNA output. Individualized cancer immunotherapies represent the most significant expansion opportunity, as patient-specific production requires frequent small-batch manufacturing, rapid release and consistent raw-material quality. Protein replacement and in vivo gene-editing therapies account for a smaller share of current demand but can generate higher value per program because enzyme performance directly affects transcript integrity, expression efficiency and safety. Suppliers capable of supporting different RNA lengths, modified nucleotides and customized template structures are best positioned to participate in these emerging applications.Regional Insights
North America remains the largest demand region, supported by commercial mRNA products, a broad clinical pipeline, leading biotechnology companies and a mature CDMO ecosystem. The region also contains several established enzyme manufacturers with strong GMP documentation, customer-audit and technical-support capabilities. Europe maintains an important position in regulated manufacturing and high-quality process raw materials, with Germany and Switzerland serving as major production and technology centers.China is the most active market for supplier localization. Domestic manufacturers have expanded from research reagents into GMP-grade T7 RNA polymerase, DNase I, capping enzymes, methyltransferases and other in vitro transcription materials. This development is shortening delivery cycles, increasing price competition and reducing dependence on imported products. Japan remains focused on specialist high-quality supply, while China Taiwan has developed a smaller base of commercial GMP RNA-production enzyme manufacturers. Other Asian markets currently have greater significance as downstream development and manufacturing locations than as independent suppliers of broad GMP enzyme portfolios.
Competitive Landscape Analysis
The competitive landscape includes global life-science reagent groups, specialized enzyme manufacturers and expanding Chinese suppliers. Established international companies compete through broad portfolios, mature quality systems, drug master files, global technical support and long-standing customer qualifications. Specialized manufacturers differentiate themselves through enzyme engineering, low-dsRNA T7 variants, high-concentration formulations and customized GMP production. Chinese suppliers increasingly compete through local manufacturing, shorter lead times, cost advantages and improving regulatory-documentation capabilities. Competitive strength is not determined by formulation volume alone, because higher-value products may be sold in smaller physical quantities. Actual manufacturing responsibility, enzyme activity, batch consistency, impurity control, scale-up experience and regulatory support remain the principal purchasing criteria. Market concentration is moderate, as customers frequently qualify more than one supplier, although switching becomes more difficult after a product enters late-stage clinical or commercial validation.Report Scope
This report studies the global GMP-Grade Process Enzymes for mRNA Manufacturing production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for GMP-Grade Process Enzymes for mRNA Manufacturing and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GMP-Grade Process Enzymes for mRNA Manufacturing that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global GMP-Grade Process Enzymes for mRNA Manufacturing total production and demand, 2021-2032, (Kg)
- Global GMP-Grade Process Enzymes for mRNA Manufacturing total production value, 2021-2032, (USD Million)
- Global GMP-Grade Process Enzymes for mRNA Manufacturing production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Kg), (based on production site)
- Global GMP-Grade Process Enzymes for mRNA Manufacturing consumption by region & country, CAGR, 2021-2032 & (Kg)
- U.S. VS China: GMP-Grade Process Enzymes for mRNA Manufacturing domestic production, consumption, key domestic manufacturers and share
- Global GMP-Grade Process Enzymes for mRNA Manufacturing production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Kg)
- Global GMP-Grade Process Enzymes for mRNA Manufacturing production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Kg)
- Global GMP-Grade Process Enzymes for mRNA Manufacturing production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Kg)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GMP-Grade Process Enzymes for mRNA Manufacturing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kg) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global GMP-Grade Process Enzymes for mRNA Manufacturing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global GMP-Grade Process Enzymes for mRNA Manufacturing Market, Segmentation by Type:
- DNA Template Amplification Enzymes
- Template Linearization Enzymes
- RNA Transcription Polymerases
- Pyrophosphate Hydrolysis Enzymes
- RNA Protection Proteins
- RNA Capping Enzymes
- Cap Methylation Enzymes
- Polyadenylation Enzymes
- DNA Template Removal Enzymes
- Other
Global GMP-Grade Process Enzymes for mRNA Manufacturing Market, Segmentation by T7 Activity Concentration:
- ≤50 U/μL
- >50–200 U/μL
- >200 U/μL
Global GMP-Grade Process Enzymes for mRNA Manufacturing Market, Segmentation by Application:
- Prophylactic Infectious Disease Vaccines
- Individualized Cancer Immunotherapies
- Protein Replacement Therapies
- In Vivo Gene Editing Therapies
- Other
Companies Profiled:
- New England Biolabs, Inc.
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Maravai LifeSciences Holdings, Inc.
- Danaher Corporation
- SignalChem Lifesciences Corporation
- Roche Holding AG
- Merck KGaA
- Canvax Reagents S.L.
- TAKARA HOLDINGS INC.
- Abnova Corporation
- Novoprotein Scientific Inc.
- Vazyme Biotech Co., Ltd.
- Yeasen Biotechnology Shanghai Co., Ltd.
- Hzymes Biotechnology Co., Ltd.
- KACTUS Biosystems
- Jiangsu Synthgene Biotechnology Co., Ltd.
- Hongene Biotech Corporation
- Seebio Biotechnology Shanghai Co., Ltd.
- Zhuhai Biori Biotechnology Co., Ltd.
- Tinzyme Co., Limited
Key Questions Answered:
1. How big is the global GMP-Grade Process Enzymes for mRNA Manufacturing market?2. What is the demand of the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
3. What is the year over year growth of the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
4. What is the production and production value of the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
5. Who are the key producers in the global GMP-Grade Process Enzymes for mRNA Manufacturing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GMP-Grade Process Enzymes for mRNA Manufacturing Introduction
1.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Supply & Forecast
1.2.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021 & 2025 & 2032)
1.2.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.2.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Pricing Trends (2021-2032)
1.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (Based on Production Site)
1.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2021-2032)
1.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (2021-2032)
1.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Region (2021-2032)
1.3.4 North America GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.3.5 Europe GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.3.6 China GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.3.7 Japan GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GMP-Grade Process Enzymes for mRNA Manufacturing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GMP-Grade Process Enzymes for mRNA Manufacturing Major Market Trends
2 DEMAND SUMMARY
2.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Demand (2021-2032)
2.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption by Region
2.2.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption by Region (2021-2026)
2.2.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Forecast by Region (2027-2032)
2.3 United States GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.4 China GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.5 Europe GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.6 Japan GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.7 South Korea GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.8 ASEAN GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.9 India GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Manufacturer (2021-2026)
3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Manufacturer (2021-2026)
3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Manufacturer (2021-2026)
3.4 GMP-Grade Process Enzymes for mRNA Manufacturing Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GMP-Grade Process Enzymes for mRNA Manufacturing Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GMP-Grade Process Enzymes for mRNA Manufacturing in 2025
3.5.3 Global Concentration Ratios (CR8) for GMP-Grade Process Enzymes for mRNA Manufacturing in 2025
3.6 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Overall Company Footprint Analysis
3.6.1 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Region Footprint
3.6.2 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Type Footprint
3.6.3 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Comparison
4.1.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Comparison
4.2.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Comparison
4.3.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers and Market Share, 2021-2026
4.4.1 United States Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021-2026)
4.4.3 United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026)
4.5 China Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers and Market Share
4.5.1 China Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021-2026)
4.5.3 China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026)
4.6 Rest of World Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DNA Template Amplification Enzymes
5.2.2 Template Linearization Enzymes
5.2.3 RNA Transcription Polymerases
5.2.4 Pyrophosphate Hydrolysis Enzymes
5.2.5 RNA Protection Proteins
5.2.6 RNA Capping Enzymes
5.2.7 Cap Methylation Enzymes
5.2.8 Polyadenylation Enzymes
5.2.9 DNA Template Removal Enzymes
5.3 Market Segment by Type
5.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Type (2021-2032)
5.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type (2021-2032)
5.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY T7 ACTIVITY CONCENTRATION
6.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Market Size Overview by T7 Activity Concentration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by T7 Activity Concentration
6.2.1 ≤50 U/μL
6.2.2 >50–200 U/μL
6.2.3 >200 U/μL
6.3 Market Segment by T7 Activity Concentration
6.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by T7 Activity Concentration (2021-2032)
6.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration (2021-2032)
6.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Prophylactic Infectious Disease Vaccines
7.2.2 Individualized Cancer Immunotherapies
7.2.3 Protein Replacement Therapies
7.2.4 In Vivo Gene Editing Therapies
7.2.5 Other
7.3 Market Segment by Application
7.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Application (2021-2032)
7.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application (2021-2032)
7.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 New England Biolabs, Inc.
8.1.1 New England Biolabs, Inc. Details
8.1.2 New England Biolabs, Inc. Major Business
8.1.3 New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.1.4 New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 New England Biolabs, Inc. Recent Developments/Updates
8.1.6 New England Biolabs, Inc. Competitive Strengths & Weaknesses
8.2 Thermo Fisher Scientific Inc.
8.2.1 Thermo Fisher Scientific Inc. Details
8.2.2 Thermo Fisher Scientific Inc. Major Business
8.2.3 Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.2.4 Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
8.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
8.3 Promega Corporation
8.3.1 Promega Corporation Details
8.3.2 Promega Corporation Major Business
8.3.3 Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.3.4 Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Promega Corporation Recent Developments/Updates
8.3.6 Promega Corporation Competitive Strengths & Weaknesses
8.4 Maravai LifeSciences Holdings, Inc.
8.4.1 Maravai LifeSciences Holdings, Inc. Details
8.4.2 Maravai LifeSciences Holdings, Inc. Major Business
8.4.3 Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.4.4 Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Maravai LifeSciences Holdings, Inc. Recent Developments/Updates
8.4.6 Maravai LifeSciences Holdings, Inc. Competitive Strengths & Weaknesses
8.5 Danaher Corporation
8.5.1 Danaher Corporation Details
8.5.2 Danaher Corporation Major Business
8.5.3 Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.5.4 Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Danaher Corporation Recent Developments/Updates
8.5.6 Danaher Corporation Competitive Strengths & Weaknesses
8.6 SignalChem Lifesciences Corporation
8.6.1 SignalChem Lifesciences Corporation Details
8.6.2 SignalChem Lifesciences Corporation Major Business
8.6.3 SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.6.4 SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 SignalChem Lifesciences Corporation Recent Developments/Updates
8.6.6 SignalChem Lifesciences Corporation Competitive Strengths & Weaknesses
8.7 Roche Holding AG
8.7.1 Roche Holding AG Details
8.7.2 Roche Holding AG Major Business
8.7.3 Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.7.4 Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Roche Holding AG Recent Developments/Updates
8.7.6 Roche Holding AG Competitive Strengths & Weaknesses
8.8 Merck KGaA
8.8.1 Merck KGaA Details
8.8.2 Merck KGaA Major Business
8.8.3 Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.8.4 Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Merck KGaA Recent Developments/Updates
8.8.6 Merck KGaA Competitive Strengths & Weaknesses
8.9 Canvax Reagents S.L.
8.9.1 Canvax Reagents S.L. Details
8.9.2 Canvax Reagents S.L. Major Business
8.9.3 Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.9.4 Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Canvax Reagents S.L. Recent Developments/Updates
8.9.6 Canvax Reagents S.L. Competitive Strengths & Weaknesses
8.10 TAKARA HOLDINGS INC.
8.10.1 TAKARA HOLDINGS INC. Details
8.10.2 TAKARA HOLDINGS INC. Major Business
8.10.3 TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.10.4 TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 TAKARA HOLDINGS INC. Recent Developments/Updates
8.10.6 TAKARA HOLDINGS INC. Competitive Strengths & Weaknesses
8.11 Abnova Corporation
8.11.1 Abnova Corporation Details
8.11.2 Abnova Corporation Major Business
8.11.3 Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.11.4 Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Abnova Corporation Recent Developments/Updates
8.11.6 Abnova Corporation Competitive Strengths & Weaknesses
8.12 Novoprotein Scientific Inc.
8.12.1 Novoprotein Scientific Inc. Details
8.12.2 Novoprotein Scientific Inc. Major Business
8.12.3 Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.12.4 Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Novoprotein Scientific Inc. Recent Developments/Updates
8.12.6 Novoprotein Scientific Inc. Competitive Strengths & Weaknesses
8.13 Vazyme Biotech Co., Ltd.
8.13.1 Vazyme Biotech Co., Ltd. Details
8.13.2 Vazyme Biotech Co., Ltd. Major Business
8.13.3 Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.13.4 Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Vazyme Biotech Co., Ltd. Recent Developments/Updates
8.13.6 Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
8.14 Yeasen Biotechnology Shanghai Co., Ltd.
8.14.1 Yeasen Biotechnology Shanghai Co., Ltd. Details
8.14.2 Yeasen Biotechnology Shanghai Co., Ltd. Major Business
8.14.3 Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.14.4 Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 Yeasen Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
8.14.6 Yeasen Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
8.15 Hzymes Biotechnology Co., Ltd.
8.15.1 Hzymes Biotechnology Co., Ltd. Details
8.15.2 Hzymes Biotechnology Co., Ltd. Major Business
8.15.3 Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.15.4 Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Hzymes Biotechnology Co., Ltd. Recent Developments/Updates
8.15.6 Hzymes Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.16 KACTUS Biosystems
8.16.1 KACTUS Biosystems Details
8.16.2 KACTUS Biosystems Major Business
8.16.3 KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.16.4 KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 KACTUS Biosystems Recent Developments/Updates
8.16.6 KACTUS Biosystems Competitive Strengths & Weaknesses
8.17 Jiangsu Synthgene Biotechnology Co., Ltd.
8.17.1 Jiangsu Synthgene Biotechnology Co., Ltd. Details
8.17.2 Jiangsu Synthgene Biotechnology Co., Ltd. Major Business
8.17.3 Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.17.4 Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 Jiangsu Synthgene Biotechnology Co., Ltd. Recent Developments/Updates
8.17.6 Jiangsu Synthgene Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.18 Hongene Biotech Corporation
8.18.1 Hongene Biotech Corporation Details
8.18.2 Hongene Biotech Corporation Major Business
8.18.3 Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.18.4 Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.18.5 Hongene Biotech Corporation Recent Developments/Updates
8.18.6 Hongene Biotech Corporation Competitive Strengths & Weaknesses
8.19 Seebio Biotechnology Shanghai Co., Ltd.
8.19.1 Seebio Biotechnology Shanghai Co., Ltd. Details
8.19.2 Seebio Biotechnology Shanghai Co., Ltd. Major Business
8.19.3 Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.19.4 Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.19.5 Seebio Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
8.19.6 Seebio Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
8.20 Zhuhai Biori Biotechnology Co., Ltd.
8.20.1 Zhuhai Biori Biotechnology Co., Ltd. Details
8.20.2 Zhuhai Biori Biotechnology Co., Ltd. Major Business
8.20.3 Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.20.4 Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.20.5 Zhuhai Biori Biotechnology Co., Ltd. Recent Developments/Updates
8.20.6 Zhuhai Biori Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.21 Tinzyme Co., Limited
8.21.1 Tinzyme Co., Limited Details
8.21.2 Tinzyme Co., Limited Major Business
8.21.3 Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.21.4 Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.21.5 Tinzyme Co., Limited Recent Developments/Updates
8.21.6 Tinzyme Co., Limited Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 GMP-Grade Process Enzymes for mRNA Manufacturing Industry Chain
9.2 GMP-Grade Process Enzymes for mRNA Manufacturing Upstream Analysis
9.2.1 GMP-Grade Process Enzymes for mRNA Manufacturing Core Raw Materials
9.2.2 Main Manufacturers of GMP-Grade Process Enzymes for mRNA Manufacturing Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 GMP-Grade Process Enzymes for mRNA Manufacturing Production Mode
9.6 GMP-Grade Process Enzymes for mRNA Manufacturing Procurement Model
9.7 GMP-Grade Process Enzymes for mRNA Manufacturing Industry Sales Model and Sales Channels
9.7.1 GMP-Grade Process Enzymes for mRNA Manufacturing Sales Model
9.7.2 GMP-Grade Process Enzymes for mRNA Manufacturing Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 GMP-Grade Process Enzymes for mRNA Manufacturing Introduction
1.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Supply & Forecast
1.2.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021 & 2025 & 2032)
1.2.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.2.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Pricing Trends (2021-2032)
1.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (Based on Production Site)
1.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2021-2032)
1.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (2021-2032)
1.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Region (2021-2032)
1.3.4 North America GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.3.5 Europe GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.3.6 China GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.3.7 Japan GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GMP-Grade Process Enzymes for mRNA Manufacturing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GMP-Grade Process Enzymes for mRNA Manufacturing Major Market Trends
2 DEMAND SUMMARY
2.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Demand (2021-2032)
2.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption by Region
2.2.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption by Region (2021-2026)
2.2.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Forecast by Region (2027-2032)
2.3 United States GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.4 China GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.5 Europe GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.6 Japan GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.7 South Korea GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.8 ASEAN GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
2.9 India GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Manufacturer (2021-2026)
3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Manufacturer (2021-2026)
3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Manufacturer (2021-2026)
3.4 GMP-Grade Process Enzymes for mRNA Manufacturing Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GMP-Grade Process Enzymes for mRNA Manufacturing Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GMP-Grade Process Enzymes for mRNA Manufacturing in 2025
3.5.3 Global Concentration Ratios (CR8) for GMP-Grade Process Enzymes for mRNA Manufacturing in 2025
3.6 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Overall Company Footprint Analysis
3.6.1 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Region Footprint
3.6.2 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Type Footprint
3.6.3 GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Comparison
4.1.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Comparison
4.2.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Comparison
4.3.1 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers and Market Share, 2021-2026
4.4.1 United States Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021-2026)
4.4.3 United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026)
4.5 China Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers and Market Share
4.5.1 China Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021-2026)
4.5.3 China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026)
4.6 Rest of World Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DNA Template Amplification Enzymes
5.2.2 Template Linearization Enzymes
5.2.3 RNA Transcription Polymerases
5.2.4 Pyrophosphate Hydrolysis Enzymes
5.2.5 RNA Protection Proteins
5.2.6 RNA Capping Enzymes
5.2.7 Cap Methylation Enzymes
5.2.8 Polyadenylation Enzymes
5.2.9 DNA Template Removal Enzymes
5.3 Market Segment by Type
5.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Type (2021-2032)
5.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type (2021-2032)
5.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY T7 ACTIVITY CONCENTRATION
6.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Market Size Overview by T7 Activity Concentration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by T7 Activity Concentration
6.2.1 ≤50 U/μL
6.2.2 >50–200 U/μL
6.2.3 >200 U/μL
6.3 Market Segment by T7 Activity Concentration
6.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by T7 Activity Concentration (2021-2032)
6.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration (2021-2032)
6.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Prophylactic Infectious Disease Vaccines
7.2.2 Individualized Cancer Immunotherapies
7.2.3 Protein Replacement Therapies
7.2.4 In Vivo Gene Editing Therapies
7.2.5 Other
7.3 Market Segment by Application
7.3.1 World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Application (2021-2032)
7.3.2 World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application (2021-2032)
7.3.3 World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 New England Biolabs, Inc.
8.1.1 New England Biolabs, Inc. Details
8.1.2 New England Biolabs, Inc. Major Business
8.1.3 New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.1.4 New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 New England Biolabs, Inc. Recent Developments/Updates
8.1.6 New England Biolabs, Inc. Competitive Strengths & Weaknesses
8.2 Thermo Fisher Scientific Inc.
8.2.1 Thermo Fisher Scientific Inc. Details
8.2.2 Thermo Fisher Scientific Inc. Major Business
8.2.3 Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.2.4 Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
8.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
8.3 Promega Corporation
8.3.1 Promega Corporation Details
8.3.2 Promega Corporation Major Business
8.3.3 Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.3.4 Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Promega Corporation Recent Developments/Updates
8.3.6 Promega Corporation Competitive Strengths & Weaknesses
8.4 Maravai LifeSciences Holdings, Inc.
8.4.1 Maravai LifeSciences Holdings, Inc. Details
8.4.2 Maravai LifeSciences Holdings, Inc. Major Business
8.4.3 Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.4.4 Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Maravai LifeSciences Holdings, Inc. Recent Developments/Updates
8.4.6 Maravai LifeSciences Holdings, Inc. Competitive Strengths & Weaknesses
8.5 Danaher Corporation
8.5.1 Danaher Corporation Details
8.5.2 Danaher Corporation Major Business
8.5.3 Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.5.4 Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Danaher Corporation Recent Developments/Updates
8.5.6 Danaher Corporation Competitive Strengths & Weaknesses
8.6 SignalChem Lifesciences Corporation
8.6.1 SignalChem Lifesciences Corporation Details
8.6.2 SignalChem Lifesciences Corporation Major Business
8.6.3 SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.6.4 SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 SignalChem Lifesciences Corporation Recent Developments/Updates
8.6.6 SignalChem Lifesciences Corporation Competitive Strengths & Weaknesses
8.7 Roche Holding AG
8.7.1 Roche Holding AG Details
8.7.2 Roche Holding AG Major Business
8.7.3 Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.7.4 Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Roche Holding AG Recent Developments/Updates
8.7.6 Roche Holding AG Competitive Strengths & Weaknesses
8.8 Merck KGaA
8.8.1 Merck KGaA Details
8.8.2 Merck KGaA Major Business
8.8.3 Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.8.4 Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Merck KGaA Recent Developments/Updates
8.8.6 Merck KGaA Competitive Strengths & Weaknesses
8.9 Canvax Reagents S.L.
8.9.1 Canvax Reagents S.L. Details
8.9.2 Canvax Reagents S.L. Major Business
8.9.3 Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.9.4 Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Canvax Reagents S.L. Recent Developments/Updates
8.9.6 Canvax Reagents S.L. Competitive Strengths & Weaknesses
8.10 TAKARA HOLDINGS INC.
8.10.1 TAKARA HOLDINGS INC. Details
8.10.2 TAKARA HOLDINGS INC. Major Business
8.10.3 TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.10.4 TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 TAKARA HOLDINGS INC. Recent Developments/Updates
8.10.6 TAKARA HOLDINGS INC. Competitive Strengths & Weaknesses
8.11 Abnova Corporation
8.11.1 Abnova Corporation Details
8.11.2 Abnova Corporation Major Business
8.11.3 Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.11.4 Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Abnova Corporation Recent Developments/Updates
8.11.6 Abnova Corporation Competitive Strengths & Weaknesses
8.12 Novoprotein Scientific Inc.
8.12.1 Novoprotein Scientific Inc. Details
8.12.2 Novoprotein Scientific Inc. Major Business
8.12.3 Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.12.4 Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Novoprotein Scientific Inc. Recent Developments/Updates
8.12.6 Novoprotein Scientific Inc. Competitive Strengths & Weaknesses
8.13 Vazyme Biotech Co., Ltd.
8.13.1 Vazyme Biotech Co., Ltd. Details
8.13.2 Vazyme Biotech Co., Ltd. Major Business
8.13.3 Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.13.4 Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 Vazyme Biotech Co., Ltd. Recent Developments/Updates
8.13.6 Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
8.14 Yeasen Biotechnology Shanghai Co., Ltd.
8.14.1 Yeasen Biotechnology Shanghai Co., Ltd. Details
8.14.2 Yeasen Biotechnology Shanghai Co., Ltd. Major Business
8.14.3 Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.14.4 Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.14.5 Yeasen Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
8.14.6 Yeasen Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
8.15 Hzymes Biotechnology Co., Ltd.
8.15.1 Hzymes Biotechnology Co., Ltd. Details
8.15.2 Hzymes Biotechnology Co., Ltd. Major Business
8.15.3 Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.15.4 Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.15.5 Hzymes Biotechnology Co., Ltd. Recent Developments/Updates
8.15.6 Hzymes Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.16 KACTUS Biosystems
8.16.1 KACTUS Biosystems Details
8.16.2 KACTUS Biosystems Major Business
8.16.3 KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.16.4 KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.16.5 KACTUS Biosystems Recent Developments/Updates
8.16.6 KACTUS Biosystems Competitive Strengths & Weaknesses
8.17 Jiangsu Synthgene Biotechnology Co., Ltd.
8.17.1 Jiangsu Synthgene Biotechnology Co., Ltd. Details
8.17.2 Jiangsu Synthgene Biotechnology Co., Ltd. Major Business
8.17.3 Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.17.4 Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.17.5 Jiangsu Synthgene Biotechnology Co., Ltd. Recent Developments/Updates
8.17.6 Jiangsu Synthgene Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.18 Hongene Biotech Corporation
8.18.1 Hongene Biotech Corporation Details
8.18.2 Hongene Biotech Corporation Major Business
8.18.3 Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.18.4 Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.18.5 Hongene Biotech Corporation Recent Developments/Updates
8.18.6 Hongene Biotech Corporation Competitive Strengths & Weaknesses
8.19 Seebio Biotechnology Shanghai Co., Ltd.
8.19.1 Seebio Biotechnology Shanghai Co., Ltd. Details
8.19.2 Seebio Biotechnology Shanghai Co., Ltd. Major Business
8.19.3 Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.19.4 Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.19.5 Seebio Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
8.19.6 Seebio Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
8.20 Zhuhai Biori Biotechnology Co., Ltd.
8.20.1 Zhuhai Biori Biotechnology Co., Ltd. Details
8.20.2 Zhuhai Biori Biotechnology Co., Ltd. Major Business
8.20.3 Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.20.4 Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.20.5 Zhuhai Biori Biotechnology Co., Ltd. Recent Developments/Updates
8.20.6 Zhuhai Biori Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
8.21 Tinzyme Co., Limited
8.21.1 Tinzyme Co., Limited Details
8.21.2 Tinzyme Co., Limited Major Business
8.21.3 Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
8.21.4 Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.21.5 Tinzyme Co., Limited Recent Developments/Updates
8.21.6 Tinzyme Co., Limited Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 GMP-Grade Process Enzymes for mRNA Manufacturing Industry Chain
9.2 GMP-Grade Process Enzymes for mRNA Manufacturing Upstream Analysis
9.2.1 GMP-Grade Process Enzymes for mRNA Manufacturing Core Raw Materials
9.2.2 Main Manufacturers of GMP-Grade Process Enzymes for mRNA Manufacturing Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 GMP-Grade Process Enzymes for mRNA Manufacturing Production Mode
9.6 GMP-Grade Process Enzymes for mRNA Manufacturing Procurement Model
9.7 GMP-Grade Process Enzymes for mRNA Manufacturing Industry Sales Model and Sales Channels
9.7.1 GMP-Grade Process Enzymes for mRNA Manufacturing Sales Model
9.7.2 GMP-Grade Process Enzymes for mRNA Manufacturing Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2021-2026) & (USD Million)
Table 3. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2027-2032) & (USD Million)
Table 4. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Region (2021-2026)
Table 5. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Region (2027-2032)
Table 6. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (2021-2026) & (Kg)
Table 7. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (2027-2032) & (Kg)
Table 8. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Region (2021-2026)
Table 9. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Region (2027-2032)
Table 10. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Region (2021-2026) & (US$/Kg)
Table 11. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Region (2027-2032) & (US$/Kg)
Table 12. GMP-Grade Process Enzymes for mRNA Manufacturing Major Market Trends
Table 13. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Kg)
Table 14. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption by Region (2021-2026) & (Kg)
Table 15. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Forecast by Region (2027-2032) & (Kg)
Table 16. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key GMP-Grade Process Enzymes for mRNA Manufacturing Producers in 2025
Table 18. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Manufacturer (2021-2026) & (Kg)
Table 19. Production Market Share of Key GMP-Grade Process Enzymes for mRNA Manufacturing Producers in 2025
Table 20. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Manufacturer (2021-2026) & (US$/Kg)
Table 21. Global GMP-Grade Process Enzymes for mRNA Manufacturing Company Evaluation Quadrant
Table 22. World GMP-Grade Process Enzymes for mRNA Manufacturing Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and GMP-Grade Process Enzymes for mRNA Manufacturing Production Site of Key Manufacturer
Table 24. GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Type Footprint
Table 25. GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Application Footprint
Table 26. GMP-Grade Process Enzymes for mRNA Manufacturing Competitive Factors
Table 27. GMP-Grade Process Enzymes for mRNA Manufacturing New Entrant and Capacity Expansion Plans
Table 28. GMP-Grade Process Enzymes for mRNA Manufacturing Mergers & Acquisitions Activity
Table 29. United States VS China GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China GMP-Grade Process Enzymes for mRNA Manufacturing Production Comparison, (2021 & 2025 & 2032) & (Kg)
Table 31. United States VS China GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Comparison, (2021 & 2025 & 2032) & (Kg)
Table 32. United States Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026) & (Kg)
Table 36. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share (2021-2026)
Table 37. China Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production, (2021-2026) & (Kg)
Table 41. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share (2021-2026)
Table 42. Rest of World Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production, (2021-2026) & (Kg)
Table 46. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share (2021-2026)
Table 47. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Type (2021-2026) & (Kg)
Table 49. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Type (2027-2032) & (Kg)
Table 50. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type (2021-2026) & (USD Million)
Table 51. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type (2027-2032) & (USD Million)
Table 52. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2021-2026) & (US$/Kg)
Table 53. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2027-2032) & (US$/Kg)
Table 54. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration, (USD Million), 2021 & 2025 & 2032
Table 55. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by T7 Activity Concentration (2021-2026) & (Kg)
Table 56. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by T7 Activity Concentration (2027-2032) & (Kg)
Table 57. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration (2021-2026) & (USD Million)
Table 58. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration (2027-2032) & (USD Million)
Table 59. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2021-2026) & (US$/Kg)
Table 60. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2027-2032) & (US$/Kg)
Table 61. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Application (2021-2026) & (Kg)
Table 63. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Application (2027-2032) & (Kg)
Table 64. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application (2021-2026) & (USD Million)
Table 65. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application (2027-2032) & (USD Million)
Table 66. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2021-2026) & (US$/Kg)
Table 67. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2027-2032) & (US$/Kg)
Table 68. New England Biolabs, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. New England Biolabs, Inc. Major Business
Table 70. New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 71. New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. New England Biolabs, Inc. Recent Developments/Updates
Table 73. New England Biolabs, Inc. Competitive Strengths & Weaknesses
Table 74. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 75. Thermo Fisher Scientific Inc. Major Business
Table 76. Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 77. Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 79. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 80. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 81. Promega Corporation Major Business
Table 82. Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 83. Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Promega Corporation Recent Developments/Updates
Table 85. Promega Corporation Competitive Strengths & Weaknesses
Table 86. Maravai LifeSciences Holdings, Inc. Basic Information, Manufacturing Base and Competitors
Table 87. Maravai LifeSciences Holdings, Inc. Major Business
Table 88. Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 89. Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Maravai LifeSciences Holdings, Inc. Recent Developments/Updates
Table 91. Maravai LifeSciences Holdings, Inc. Competitive Strengths & Weaknesses
Table 92. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 93. Danaher Corporation Major Business
Table 94. Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 95. Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Danaher Corporation Recent Developments/Updates
Table 97. Danaher Corporation Competitive Strengths & Weaknesses
Table 98. SignalChem Lifesciences Corporation Basic Information, Manufacturing Base and Competitors
Table 99. SignalChem Lifesciences Corporation Major Business
Table 100. SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 101. SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. SignalChem Lifesciences Corporation Recent Developments/Updates
Table 103. SignalChem Lifesciences Corporation Competitive Strengths & Weaknesses
Table 104. Roche Holding AG Basic Information, Manufacturing Base and Competitors
Table 105. Roche Holding AG Major Business
Table 106. Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 107. Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Roche Holding AG Recent Developments/Updates
Table 109. Roche Holding AG Competitive Strengths & Weaknesses
Table 110. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 111. Merck KGaA Major Business
Table 112. Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 113. Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Merck KGaA Recent Developments/Updates
Table 115. Merck KGaA Competitive Strengths & Weaknesses
Table 116. Canvax Reagents S.L. Basic Information, Manufacturing Base and Competitors
Table 117. Canvax Reagents S.L. Major Business
Table 118. Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 119. Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Canvax Reagents S.L. Recent Developments/Updates
Table 121. Canvax Reagents S.L. Competitive Strengths & Weaknesses
Table 122. TAKARA HOLDINGS INC. Basic Information, Manufacturing Base and Competitors
Table 123. TAKARA HOLDINGS INC. Major Business
Table 124. TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 125. TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. TAKARA HOLDINGS INC. Recent Developments/Updates
Table 127. TAKARA HOLDINGS INC. Competitive Strengths & Weaknesses
Table 128. Abnova Corporation Basic Information, Manufacturing Base and Competitors
Table 129. Abnova Corporation Major Business
Table 130. Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 131. Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Abnova Corporation Recent Developments/Updates
Table 133. Abnova Corporation Competitive Strengths & Weaknesses
Table 134. Novoprotein Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 135. Novoprotein Scientific Inc. Major Business
Table 136. Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 137. Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Novoprotein Scientific Inc. Recent Developments/Updates
Table 139. Novoprotein Scientific Inc. Competitive Strengths & Weaknesses
Table 140. Vazyme Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 141. Vazyme Biotech Co., Ltd. Major Business
Table 142. Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 143. Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Vazyme Biotech Co., Ltd. Recent Developments/Updates
Table 145. Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 146. Yeasen Biotechnology Shanghai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 147. Yeasen Biotechnology Shanghai Co., Ltd. Major Business
Table 148. Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 149. Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Yeasen Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
Table 151. Yeasen Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
Table 152. Hzymes Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 153. Hzymes Biotechnology Co., Ltd. Major Business
Table 154. Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 155. Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Hzymes Biotechnology Co., Ltd. Recent Developments/Updates
Table 157. Hzymes Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 158. KACTUS Biosystems Basic Information, Manufacturing Base and Competitors
Table 159. KACTUS Biosystems Major Business
Table 160. KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 161. KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. KACTUS Biosystems Recent Developments/Updates
Table 163. KACTUS Biosystems Competitive Strengths & Weaknesses
Table 164. Jiangsu Synthgene Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 165. Jiangsu Synthgene Biotechnology Co., Ltd. Major Business
Table 166. Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 167. Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. Jiangsu Synthgene Biotechnology Co., Ltd. Recent Developments/Updates
Table 169. Jiangsu Synthgene Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 170. Hongene Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 171. Hongene Biotech Corporation Major Business
Table 172. Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 173. Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 174. Hongene Biotech Corporation Recent Developments/Updates
Table 175. Hongene Biotech Corporation Competitive Strengths & Weaknesses
Table 176. Seebio Biotechnology Shanghai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 177. Seebio Biotechnology Shanghai Co., Ltd. Major Business
Table 178. Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 179. Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Seebio Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
Table 181. Seebio Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
Table 182. Zhuhai Biori Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 183. Zhuhai Biori Biotechnology Co., Ltd. Major Business
Table 184. Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 185. Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 186. Zhuhai Biori Biotechnology Co., Ltd. Recent Developments/Updates
Table 187. Zhuhai Biori Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 188. Tinzyme Co., Limited Basic Information, Manufacturing Base and Competitors
Table 189. Tinzyme Co., Limited Major Business
Table 190. Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 191. Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 192. Tinzyme Co., Limited Recent Developments/Updates
Table 193. Tinzyme Co., Limited Competitive Strengths & Weaknesses
Table 194. Global Key Players of GMP-Grade Process Enzymes for mRNA Manufacturing Upstream (Raw Materials)
Table 195. Global GMP-Grade Process Enzymes for mRNA Manufacturing Typical Customers
Table 196. GMP-Grade Process Enzymes for mRNA Manufacturing Typical Distributors
Table 1. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2021-2026) & (USD Million)
Table 3. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Region (2027-2032) & (USD Million)
Table 4. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Region (2021-2026)
Table 5. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Region (2027-2032)
Table 6. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (2021-2026) & (Kg)
Table 7. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Region (2027-2032) & (Kg)
Table 8. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Region (2021-2026)
Table 9. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Region (2027-2032)
Table 10. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Region (2021-2026) & (US$/Kg)
Table 11. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Region (2027-2032) & (US$/Kg)
Table 12. GMP-Grade Process Enzymes for mRNA Manufacturing Major Market Trends
Table 13. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Kg)
Table 14. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption by Region (2021-2026) & (Kg)
Table 15. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Forecast by Region (2027-2032) & (Kg)
Table 16. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key GMP-Grade Process Enzymes for mRNA Manufacturing Producers in 2025
Table 18. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Manufacturer (2021-2026) & (Kg)
Table 19. Production Market Share of Key GMP-Grade Process Enzymes for mRNA Manufacturing Producers in 2025
Table 20. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Manufacturer (2021-2026) & (US$/Kg)
Table 21. Global GMP-Grade Process Enzymes for mRNA Manufacturing Company Evaluation Quadrant
Table 22. World GMP-Grade Process Enzymes for mRNA Manufacturing Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and GMP-Grade Process Enzymes for mRNA Manufacturing Production Site of Key Manufacturer
Table 24. GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Type Footprint
Table 25. GMP-Grade Process Enzymes for mRNA Manufacturing Market: Company Product Application Footprint
Table 26. GMP-Grade Process Enzymes for mRNA Manufacturing Competitive Factors
Table 27. GMP-Grade Process Enzymes for mRNA Manufacturing New Entrant and Capacity Expansion Plans
Table 28. GMP-Grade Process Enzymes for mRNA Manufacturing Mergers & Acquisitions Activity
Table 29. United States VS China GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China GMP-Grade Process Enzymes for mRNA Manufacturing Production Comparison, (2021 & 2025 & 2032) & (Kg)
Table 31. United States VS China GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Comparison, (2021 & 2025 & 2032) & (Kg)
Table 32. United States Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2026) & (Kg)
Table 36. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share (2021-2026)
Table 37. China Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production, (2021-2026) & (Kg)
Table 41. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share (2021-2026)
Table 42. Rest of World Based GMP-Grade Process Enzymes for mRNA Manufacturing Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production, (2021-2026) & (Kg)
Table 46. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share (2021-2026)
Table 47. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Type (2021-2026) & (Kg)
Table 49. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Type (2027-2032) & (Kg)
Table 50. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type (2021-2026) & (USD Million)
Table 51. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type (2027-2032) & (USD Million)
Table 52. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2021-2026) & (US$/Kg)
Table 53. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2027-2032) & (US$/Kg)
Table 54. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration, (USD Million), 2021 & 2025 & 2032
Table 55. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by T7 Activity Concentration (2021-2026) & (Kg)
Table 56. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by T7 Activity Concentration (2027-2032) & (Kg)
Table 57. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration (2021-2026) & (USD Million)
Table 58. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration (2027-2032) & (USD Million)
Table 59. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2021-2026) & (US$/Kg)
Table 60. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2027-2032) & (US$/Kg)
Table 61. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Application (2021-2026) & (Kg)
Table 63. World GMP-Grade Process Enzymes for mRNA Manufacturing Production by Application (2027-2032) & (Kg)
Table 64. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application (2021-2026) & (USD Million)
Table 65. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application (2027-2032) & (USD Million)
Table 66. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2021-2026) & (US$/Kg)
Table 67. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2027-2032) & (US$/Kg)
Table 68. New England Biolabs, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. New England Biolabs, Inc. Major Business
Table 70. New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 71. New England Biolabs, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. New England Biolabs, Inc. Recent Developments/Updates
Table 73. New England Biolabs, Inc. Competitive Strengths & Weaknesses
Table 74. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 75. Thermo Fisher Scientific Inc. Major Business
Table 76. Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 77. Thermo Fisher Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 79. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 80. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 81. Promega Corporation Major Business
Table 82. Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 83. Promega Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Promega Corporation Recent Developments/Updates
Table 85. Promega Corporation Competitive Strengths & Weaknesses
Table 86. Maravai LifeSciences Holdings, Inc. Basic Information, Manufacturing Base and Competitors
Table 87. Maravai LifeSciences Holdings, Inc. Major Business
Table 88. Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 89. Maravai LifeSciences Holdings, Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Maravai LifeSciences Holdings, Inc. Recent Developments/Updates
Table 91. Maravai LifeSciences Holdings, Inc. Competitive Strengths & Weaknesses
Table 92. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 93. Danaher Corporation Major Business
Table 94. Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 95. Danaher Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Danaher Corporation Recent Developments/Updates
Table 97. Danaher Corporation Competitive Strengths & Weaknesses
Table 98. SignalChem Lifesciences Corporation Basic Information, Manufacturing Base and Competitors
Table 99. SignalChem Lifesciences Corporation Major Business
Table 100. SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 101. SignalChem Lifesciences Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. SignalChem Lifesciences Corporation Recent Developments/Updates
Table 103. SignalChem Lifesciences Corporation Competitive Strengths & Weaknesses
Table 104. Roche Holding AG Basic Information, Manufacturing Base and Competitors
Table 105. Roche Holding AG Major Business
Table 106. Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 107. Roche Holding AG GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Roche Holding AG Recent Developments/Updates
Table 109. Roche Holding AG Competitive Strengths & Weaknesses
Table 110. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 111. Merck KGaA Major Business
Table 112. Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 113. Merck KGaA GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Merck KGaA Recent Developments/Updates
Table 115. Merck KGaA Competitive Strengths & Weaknesses
Table 116. Canvax Reagents S.L. Basic Information, Manufacturing Base and Competitors
Table 117. Canvax Reagents S.L. Major Business
Table 118. Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 119. Canvax Reagents S.L. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Canvax Reagents S.L. Recent Developments/Updates
Table 121. Canvax Reagents S.L. Competitive Strengths & Weaknesses
Table 122. TAKARA HOLDINGS INC. Basic Information, Manufacturing Base and Competitors
Table 123. TAKARA HOLDINGS INC. Major Business
Table 124. TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 125. TAKARA HOLDINGS INC. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. TAKARA HOLDINGS INC. Recent Developments/Updates
Table 127. TAKARA HOLDINGS INC. Competitive Strengths & Weaknesses
Table 128. Abnova Corporation Basic Information, Manufacturing Base and Competitors
Table 129. Abnova Corporation Major Business
Table 130. Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 131. Abnova Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Abnova Corporation Recent Developments/Updates
Table 133. Abnova Corporation Competitive Strengths & Weaknesses
Table 134. Novoprotein Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 135. Novoprotein Scientific Inc. Major Business
Table 136. Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 137. Novoprotein Scientific Inc. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Novoprotein Scientific Inc. Recent Developments/Updates
Table 139. Novoprotein Scientific Inc. Competitive Strengths & Weaknesses
Table 140. Vazyme Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 141. Vazyme Biotech Co., Ltd. Major Business
Table 142. Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 143. Vazyme Biotech Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Vazyme Biotech Co., Ltd. Recent Developments/Updates
Table 145. Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 146. Yeasen Biotechnology Shanghai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 147. Yeasen Biotechnology Shanghai Co., Ltd. Major Business
Table 148. Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 149. Yeasen Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. Yeasen Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
Table 151. Yeasen Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
Table 152. Hzymes Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 153. Hzymes Biotechnology Co., Ltd. Major Business
Table 154. Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 155. Hzymes Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 156. Hzymes Biotechnology Co., Ltd. Recent Developments/Updates
Table 157. Hzymes Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 158. KACTUS Biosystems Basic Information, Manufacturing Base and Competitors
Table 159. KACTUS Biosystems Major Business
Table 160. KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 161. KACTUS Biosystems GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 162. KACTUS Biosystems Recent Developments/Updates
Table 163. KACTUS Biosystems Competitive Strengths & Weaknesses
Table 164. Jiangsu Synthgene Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 165. Jiangsu Synthgene Biotechnology Co., Ltd. Major Business
Table 166. Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 167. Jiangsu Synthgene Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 168. Jiangsu Synthgene Biotechnology Co., Ltd. Recent Developments/Updates
Table 169. Jiangsu Synthgene Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 170. Hongene Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 171. Hongene Biotech Corporation Major Business
Table 172. Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 173. Hongene Biotech Corporation GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 174. Hongene Biotech Corporation Recent Developments/Updates
Table 175. Hongene Biotech Corporation Competitive Strengths & Weaknesses
Table 176. Seebio Biotechnology Shanghai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 177. Seebio Biotechnology Shanghai Co., Ltd. Major Business
Table 178. Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 179. Seebio Biotechnology Shanghai Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Seebio Biotechnology Shanghai Co., Ltd. Recent Developments/Updates
Table 181. Seebio Biotechnology Shanghai Co., Ltd. Competitive Strengths & Weaknesses
Table 182. Zhuhai Biori Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 183. Zhuhai Biori Biotechnology Co., Ltd. Major Business
Table 184. Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 185. Zhuhai Biori Biotechnology Co., Ltd. GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 186. Zhuhai Biori Biotechnology Co., Ltd. Recent Developments/Updates
Table 187. Zhuhai Biori Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 188. Tinzyme Co., Limited Basic Information, Manufacturing Base and Competitors
Table 189. Tinzyme Co., Limited Major Business
Table 190. Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Product and Services
Table 191. Tinzyme Co., Limited GMP-Grade Process Enzymes for mRNA Manufacturing Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 192. Tinzyme Co., Limited Recent Developments/Updates
Table 193. Tinzyme Co., Limited Competitive Strengths & Weaknesses
Table 194. Global Key Players of GMP-Grade Process Enzymes for mRNA Manufacturing Upstream (Raw Materials)
Table 195. Global GMP-Grade Process Enzymes for mRNA Manufacturing Typical Customers
Table 196. GMP-Grade Process Enzymes for mRNA Manufacturing Typical Distributors
LIST OF FIGURES
Figure 1. GMP-Grade Process Enzymes for mRNA Manufacturing Picture
Figure 2. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 5. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price (2021-2032) & (US$/Kg)
Figure 6. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Region (2021-2032)
Figure 7. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Region (2021-2032)
Figure 8. North America GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 9. Europe GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 10. China GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 11. Japan GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 12. GMP-Grade Process Enzymes for mRNA Manufacturing Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 15. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Market Share by Region (2021-2032)
Figure 16. United States GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 17. China GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 18. Europe GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 19. Japan GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 20. South Korea GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 21. ASEAN GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 22. India GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 23. Producer Shipments of GMP-Grade Process Enzymes for mRNA Manufacturing by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for GMP-Grade Process Enzymes for mRNA Manufacturing Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for GMP-Grade Process Enzymes for mRNA Manufacturing Markets in 2025
Figure 26. United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share 2025
Figure 30. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share 2025
Figure 31. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share 2025
Figure 32. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Type in 2025
Figure 34. DNA Template Amplification Enzymes
Figure 35. Template Linearization Enzymes
Figure 36. RNA Transcription Polymerases
Figure 37. Pyrophosphate Hydrolysis Enzymes
Figure 38. RNA Protection Proteins
Figure 39. RNA Capping Enzymes
Figure 40. Cap Methylation Enzymes
Figure 41. Polyadenylation Enzymes
Figure 42. Cap Methylation Enzymes
Figure 43. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Type (2021-2032)
Figure 44. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Type (2021-2032)
Figure 45. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2021-2032) & (US$/Kg)
Figure 46. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration, (USD Million), 2021 & 2025 & 2032
Figure 47. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by T7 Activity Concentration in 2025
Figure 48. ≤50 U/μL
Figure 49. >50–200 U/μL
Figure 50. >200 U/μL
Figure 51. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by T7 Activity Concentration (2021-2032)
Figure 52. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by T7 Activity Concentration (2021-2032)
Figure 53. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2021-2032) & (US$/Kg)
Figure 54. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Application in 2025
Figure 56. Prophylactic Infectious Disease Vaccines
Figure 57. Individualized Cancer Immunotherapies
Figure 58. Protein Replacement Therapies
Figure 59. In Vivo Gene Editing Therapies
Figure 60. Other
Figure 61. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Application (2021-2032)
Figure 62. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Application (2021-2032)
Figure 63. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2021-2032) & (US$/Kg)
Figure 64. GMP-Grade Process Enzymes for mRNA Manufacturing Industry Chain
Figure 65. GMP-Grade Process Enzymes for mRNA Manufacturing Procurement Model
Figure 66. GMP-Grade Process Enzymes for mRNA Manufacturing Sales Model
Figure 67. GMP-Grade Process Enzymes for mRNA Manufacturing Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. GMP-Grade Process Enzymes for mRNA Manufacturing Picture
Figure 2. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 5. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price (2021-2032) & (US$/Kg)
Figure 6. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Region (2021-2032)
Figure 7. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Region (2021-2032)
Figure 8. North America GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 9. Europe GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 10. China GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 11. Japan GMP-Grade Process Enzymes for mRNA Manufacturing Production (2021-2032) & (Kg)
Figure 12. GMP-Grade Process Enzymes for mRNA Manufacturing Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 15. World GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Market Share by Region (2021-2032)
Figure 16. United States GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 17. China GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 18. Europe GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 19. Japan GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 20. South Korea GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 21. ASEAN GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 22. India GMP-Grade Process Enzymes for mRNA Manufacturing Consumption (2021-2032) & (Kg)
Figure 23. Producer Shipments of GMP-Grade Process Enzymes for mRNA Manufacturing by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for GMP-Grade Process Enzymes for mRNA Manufacturing Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for GMP-Grade Process Enzymes for mRNA Manufacturing Markets in 2025
Figure 26. United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: GMP-Grade Process Enzymes for mRNA Manufacturing Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share 2025
Figure 30. China Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share 2025
Figure 31. Rest of World Based Manufacturers GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share 2025
Figure 32. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Type in 2025
Figure 34. DNA Template Amplification Enzymes
Figure 35. Template Linearization Enzymes
Figure 36. RNA Transcription Polymerases
Figure 37. Pyrophosphate Hydrolysis Enzymes
Figure 38. RNA Protection Proteins
Figure 39. RNA Capping Enzymes
Figure 40. Cap Methylation Enzymes
Figure 41. Polyadenylation Enzymes
Figure 42. Cap Methylation Enzymes
Figure 43. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Type (2021-2032)
Figure 44. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Type (2021-2032)
Figure 45. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Type (2021-2032) & (US$/Kg)
Figure 46. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by T7 Activity Concentration, (USD Million), 2021 & 2025 & 2032
Figure 47. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by T7 Activity Concentration in 2025
Figure 48. ≤50 U/μL
Figure 49. >50–200 U/μL
Figure 50. >200 U/μL
Figure 51. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by T7 Activity Concentration (2021-2032)
Figure 52. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by T7 Activity Concentration (2021-2032)
Figure 53. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by T7 Activity Concentration (2021-2032) & (US$/Kg)
Figure 54. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Application in 2025
Figure 56. Prophylactic Infectious Disease Vaccines
Figure 57. Individualized Cancer Immunotherapies
Figure 58. Protein Replacement Therapies
Figure 59. In Vivo Gene Editing Therapies
Figure 60. Other
Figure 61. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Market Share by Application (2021-2032)
Figure 62. World GMP-Grade Process Enzymes for mRNA Manufacturing Production Value Market Share by Application (2021-2032)
Figure 63. World GMP-Grade Process Enzymes for mRNA Manufacturing Average Price by Application (2021-2032) & (US$/Kg)
Figure 64. GMP-Grade Process Enzymes for mRNA Manufacturing Industry Chain
Figure 65. GMP-Grade Process Enzymes for mRNA Manufacturing Procurement Model
Figure 66. GMP-Grade Process Enzymes for mRNA Manufacturing Sales Model
Figure 67. GMP-Grade Process Enzymes for mRNA Manufacturing Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
